Besides arrhythmias, CaMKII is strongly increased during myocardial injury (Ren et al., 2003), atrial fibrillation (Liu et al., 2019), cardiac hypertrophy (Kamada et al., 2019), ischemia/reperfusion injury (Rajtik et al., 2016), and heart failure (HF) (Beckendorf et al., 2018). This evidence concerns the gene CAMK2G and atrial fibrillation.